世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000033139

G8諸国におけるジェネリック医薬品市場の概要、競合分析、および予測(2017‐2026年)

MarketLine

G8 Countries Generics Market Summary, Competitive Analysis and Forecast, 2017-2026

発刊日 2022/08/20

言語英語

体裁PDF/182ページ

ライセンス/価格182ページ

0000033139

Single
Site
Enterprisewide (Global Site)

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

G8諸国のジェネリック医薬品業界プロファイルは、市場シェア、市場規模(2017年から2021年の価値および2026年までの予測)を含むトップラインの定性的および定量的な概要情報を提供します。また、主要な財務指標や市場内の競争圧力の分析など、主要企業に関する情報も含まれています。

主要なハイライト

  • G8諸国は2021年に1,578億920万ドルを世界のジェネリック医薬品産業に貢献し、2017年から2021年の複合年間成長率(CAGR)は3%でした。G8諸国は2026年には1,808億6,840万ドルに達し、2021年から26年までのCAGRは2.8%と予測されます。
  • G8諸国の中で、アメリカはジェネリック業界の主要国であり、2021 年の市場収益は 650 億 1,560 万ドルです。次いで、日本が285億6,860万ドル、ドイツが262億3,870万ドルとなっています。
  • 2016年のG8諸国におけるジェネリック医薬品産業の規模は、アメリカが716億2,670万ドルでトップ、次いで日本が315億9,640万ドル、ドイツが303億6810万ドルと予測されています。

調査範囲

  • G8諸国のジェネリック医薬品市場の規模、成長、主要セグメント、主要プレーヤーを特定することで、初歩的な調査にかかる時間を短縮できます。
  • ファイブフォース分析により、G8諸国のジェネリック医薬品市場の競争力、魅力度を判断できます。
  • 大手企業のプロファイルは、主要なジェネリック医薬品市場におけるG8諸国のプレーヤーのグローバルな事業と財務実績の詳細を明らかにします。
  • 5年間の予測でG8諸国のジェネリック医薬品市場の将来の成長見通しを理解することにより、プレゼンテーションと売り込みに重みを加えることができます。
  • アメリカ、カナダ、ドイツ、フランス、イギリス、イタリア、ロシア、日本のデータを比較し、それぞれの国について個別のチャプターを設けています。

レポート詳細

目次

Table of Contents

1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions

2 Group of Eight (G8) Generics
2.1. Industry Outlook

3 Generics in Canada
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis

4 Macroeconomic Indicators
4.1. Country data

5 Generics in France
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis

6 Macroeconomic Indicators
6.1. Country data

7 Generics in Germany
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis

8 Macroeconomic Indicators
8.1. Country data

9 Generics in Italy
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis

10 Macroeconomic Indicators
10.1. Country data

11 Generics in Japan
11.1. Market Overview
11.2. Market Data
11.3. Market Segmentation
11.4. Market outlook
11.5. Five forces analysis

12 Macroeconomic Indicators
12.1. Country data

13 Generics in Russia
13.1. Market Overview
13.2. Market Data
13.3. Market Segmentation
13.4. Market outlook
13.5. Five forces analysis

14 Macroeconomic Indicators
14.1. Country data

15 Generics in The United Kingdom
15.1. Market Overview
15.2. Market Data
15.3. Market Segmentation
15.4. Market outlook
15.5. Five forces analysis

16 Macroeconomic Indicators
16.1. Country data

17 Generics in The United States
17.1. Market Overview
17.2. Market Data
17.3. Market Segmentation
17.4. Market outlook
17.5. Five forces analysis

18 Macroeconomic Indicators
18.1. Country data

19 Company Profiles

20 Appendix
20.1. Methodology
20.2. About MarketLine

List of Tables
Table 1: G8 generics industry, revenue($m), 2017-26
Table 2: G8 generics industry, revenue by country ($m), 2017-21
Table 3: G8 generics industry forecast, revenue by country ($m), 2021-26
Table 4: Canada generics market value: $ million, 2016-21
Table 5: Canada generics market volume: %, 2016-21
Table 6: Canada generics market geography segmentation: $ million, 2021
Table 7: Canada generics market value forecast: $ million, 2021-26
Table 8: Canada generics market volume forecast: %, 2021-26
Table 9: Canada size of population (million), 2017-21
Table 10: Canada gdp (constant 2005 prices, $ billion), 2017-21
Table 11: Canada gdp (current prices, $ billion), 2017-21
Table 12: Canada inflation, 2017-21
Table 13: Canada consumer price index (absolute), 2017-21
Table 14: Canada exchange rate, 2017-21
Table 15: France generics market value: $ million, 2016-21
Table 16: France generics market volume: %, 2016-21
Table 17: France generics market geography segmentation: $ million, 2021
Table 18: France generics market value forecast: $ million, 2021-26
Table 19: France generics market volume forecast: %, 2021-26
Table 20: France size of population (million), 2017-21
Table 21: France gdp (constant 2005 prices, $ billion), 2017-21
Table 22: France gdp (current prices, $ billion), 2017-21
Table 23: France inflation, 2017-21
Table 24: France consumer price index (absolute), 2017-21
Table 25: France exchange rate, 2017-21
Table 26: Germany generics market value: $ billion, 2016-21
Table 27: Germany generics market volume: %, 2016-21
Table 28: Germany generics market geography segmentation: $ billion, 2021
Table 29: Germany generics market value forecast: $ billion, 2021-26
Table 30: Germany generics market volume forecast: %, 2021-26
Table 31: Germany size of population (million), 2017-21
Table 32: Germany gdp (constant 2005 prices, $ billion), 2017-21
Table 33: Germany gdp (current prices, $ billion), 2017-21
Table 34: Germany inflation, 2017-21
Table 35: Germany consumer price index (absolute), 2017-21
Table 36: Germany exchange rate, 2017-21
Table 37: Italy generics market value: $ million, 2016-21
Table 38: Italy generics market volume: %, 2016-21
Table 39: Italy generics market geography segmentation: $ million, 2021
Table 40: Italy generics market value forecast: $ million, 2021-26
Table 41: Italy generics market volume forecast: %, 2021-26
Table 42: Italy size of population (million), 2017-21
Table 43: Italy gdp (constant 2005 prices, $ billion), 2017-21
Table 44: Italy gdp (current prices, $ billion), 2017-21
Table 45: Italy inflation, 2017-21
Table 46: Italy consumer price index (absolute), 2017-21
Table 47: Italy exchange rate, 2017-21
Table 48: Japan generics market value: $ billion, 2016-21
Table 49: Japan generics market volume: %, 2016-21
Table 50: Japan generics market geography segmentation: $ billion, 2021
Table 51: Japan generics market value forecast: $ billion, 2021-26
Table 52: Japan generics market volume forecast: %, 2021-26
Table 53: Japan size of population (million), 2017-21
Table 54: Japan gdp (constant 2005 prices, $ billion), 2017-21
Table 55: Japan gdp (current prices, $ billion), 2017-21
Table 56: Japan inflation, 2017-21
Table 57: Japan consumer price index (absolute), 2017-21
Table 58: Japan exchange rate, 2017-21
Table 59: Russia generics market value: $ million, 2016-21
Table 60: Russia generics market volume: %, 2016-21
Table 61: Russia generics market geography segmentation: $ million, 2021
Table 62: Russia generics market value forecast: $ million, 2021-26
Table 63: Russia generics market volume forecast: %, 2021-26
Table 64: Russia size of population (million), 2017-21
Table 65: Russia gdp (constant 2005 prices, $ billion), 2017-21
Table 66: Russia gdp (current prices, $ billion), 2017-21
Table 67: Russia inflation, 2017-21
Table 68: Russia consumer price index (absolute), 2017-21
Table 69: Russia exchange rate, 2017-21
Table 70: United Kingdom generics market value: $ billion, 2016-21
Table 71: United Kingdom generics market volume: %, 2016-21
Table 72: United Kingdom generics market geography segmentation: $ billion, 2021
Table 73: United Kingdom generics market value forecast: $ billion, 2021-26
Table 74: United Kingdom generics market volume forecast: %, 2021-26
Table 75: United Kingdom size of population (million), 2017-21
Table 76: United Kingdom gdp (constant 2005 prices, $ billion), 2017-21
Table 77: United Kingdom gdp (current prices, $ billion), 2017-21
Table 78: United Kingdom inflation, 2017-21
Table 79: United Kingdom consumer price index (absolute), 2017-21
Table 80: United Kingdom exchange rate, 2017-21

List of Figures
Figure 1: G8 generics industry, revenue($m), 2017-26
Figure 2: G8 Generics industry, revenue by country (%), 2021
Figure 3: G8 generics industry, revenue by country ($m), 2017-21
Figure 4: G8 generics industry forecast, revenue by country ($m), 2021-26
Figure 5: Canada generics market value: $ million, 2016-21
Figure 6: Canada generics market volume: %, 2016-21
Figure 7: Canada generics market geography segmentation: % share, by value, 2021
Figure 8: Canada generics market value forecast: $ million, 2021-26
Figure 9: Canada generics market volume forecast: %, 2021-26
Figure 10: Forces driving competition in the generics market in Canada, 2021
Figure 11: Drivers of buyer power in the generics market in Canada, 2021
Figure 12: Drivers of supplier power in the generics market in Canada, 2021
Figure 13: Factors influencing the likelihood of new entrants in the generics market in Canada, 2021
Figure 14: Factors influencing the threat of substitutes in the generics market in Canada, 2021
Figure 15: Drivers of degree of rivalry in the generics market in Canada, 2021
Figure 16: France generics market value: $ million, 2016-21
Figure 17: France generics market volume: %, 2016-21
Figure 18: France generics market geography segmentation: % share, by value, 2021
Figure 19: France generics market value forecast: $ million, 2021-26
Figure 20: France generics market volume forecast: %, 2021-26
Figure 21: Forces driving competition in the generics market in France, 2021
Figure 22: Drivers of buyer power in the generics market in France, 2021
Figure 23: Drivers of supplier power in the generics market in France, 2021
Figure 24: Factors influencing the likelihood of new entrants in the generics market in France, 2021
Figure 25: Factors influencing the threat of substitutes in the generics market in France, 2021
Figure 26: Drivers of degree of rivalry in the generics market in France, 2021
Figure 27: Germany generics market value: $ billion, 2016-21
Figure 28: Germany generics market volume: %, 2016-21
Figure 29: Germany generics market geography segmentation: % share, by value, 2021
Figure 30: Germany generics market value forecast: $ billion, 2021-26
Figure 31: Germany generics market volume forecast: %, 2021-26
Figure 32: Forces driving competition in the generics market in Germany, 2021
Figure 33: Drivers of buyer power in the generics market in Germany, 2021
Figure 34: Drivers of supplier power in the generics market in Germany, 2021
Figure 35: Factors influencing the likelihood of new entrants in the generics market in Germany, 2021
Figure 36: Factors influencing the threat of substitutes in the generics market in Germany, 2021
Figure 37: Drivers of degree of rivalry in the generics market in Germany, 2021
Figure 38: Italy generics market value: $ million, 2016-21
Figure 39: Italy generics market volume: %, 2016-21
Figure 40: Italy generics market geography segmentation: % share, by value, 2021
Figure 41: Italy generics market value forecast: $ million, 2021-26
Figure 42: Italy generics market volume forecast: %, 2021-26
Figure 43: Forces driving competition in the generics market in Italy, 2021
Figure 44: Drivers of buyer power in the generics market in Italy, 2021
Figure 45: Drivers of supplier power in the generics market in Italy, 2021
Figure 46: Factors influencing the likelihood of new entrants in the generics market in Italy, 2021
Figure 47: Factors influencing the threat of substitutes in the generics market in Italy, 2021
Figure 48: Drivers of degree of rivalry in the generics market in Italy, 2021
Figure 49: Japan generics market value: $ billion, 2016-21
Figure 50: Japan generics market volume: %, 2016-21
Figure 51: Japan generics market geography segmentation: % share, by value, 2021
Figure 52: Japan generics market value forecast: $ billion, 2021-26
Figure 53: Japan generics market volume forecast: %, 2021-26
Figure 54: Forces driving competition in the generics market in Japan, 2021
Figure 55: Drivers of buyer power in the generics market in Japan, 2021
Figure 56: Drivers of supplier power in the generics market in Japan, 2021
Figure 57: Factors influencing the likelihood of new entrants in the generics market in Japan, 2021
Figure 58: Factors influencing the threat of substitutes in the generics market in Japan, 2021
Figure 59: Drivers of degree of rivalry in the generics market in Japan, 2021
Figure 60: Russia generics market value: $ million, 2016-21
Figure 61: Russia generics market volume: %, 2016-21
Figure 62: Russia generics market geography segmentation: % share, by value, 2021
Figure 63: Russia generics market value forecast: $ million, 2021-26
Figure 64: Russia generics market volume forecast: %, 2021-26
Figure 65: Forces driving competition in the generics market in Russia, 2021
Figure 66: Drivers of buyer power in the generics market in Russia, 2021
Figure 67: Drivers of supplier power in the generics market in Russia, 2021
Figure 68: Factors influencing the likelihood of new entrants in the generics market in Russia, 2021
Figure 69: Factors influencing the threat of substitutes in the generics market in Russia, 2021
Figure 70: Drivers of degree of rivalry in the generics market in Russia, 2021
Figure 71: United Kingdom generics market value: $ billion, 2016-21
Figure 72: United Kingdom generics market volume: %, 2016-21
Figure 73: United Kingdom generics market geography segmentation: % share, by value, 2021
Figure 74: United Kingdom generics market value forecast: $ billion, 2021-26
Figure 75: United Kingdom generics market volume forecast: %, 2021-26
Figure 76: Forces driving competition in the generics market in the United Kingdom, 2021
Figure 77: Drivers of buyer power in the generics market in the United Kingdom, 2021
Figure 78: Drivers of supplier power in the generics market in the United Kingdom, 2021
Figure 79: Factors influencing the likelihood of new entrants in the generics market in the United Kingdom, 2021
Figure 80: Factors influencing the threat of substitutes in the generics market in the United Kingdom, 2021

この商品のレポートナンバー

0000033139

TOP